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Renal handling of lysozyme in the rat. The aim of the present
study is to analyze the renal handling of lysozyme with special
reference to whether or not a transtubular transport of intact
lysozyme occurs. Thirty minutes after injection of '251-lysozyme,
41.3 (sEM) 1.7% of the injected dose is accumulated in the
kidneys where it is primarily located in the lysosomes, as demon-
strated by differential centrifugation and electron microscope au-
toradiography. Thirty minutes after injection of 125l-lysozyme in-
to one animal (donor), blood from this animal was cross-circu-
lated to a second animal (acceptor) and the uptake of 12I
lysozyme in the acceptor's kidneys determined. The uptake of
25I-lysozyme in the acceptor kidneys provides a sensitive meth-
od of detecting minor changes in the 2I-1ysozyme concentration
in the donor's blood during different experimental situations.
Comparison of experiments with normal donors and binephrec-
tomized donors demonstrates that the kidney removes more 125J..
lysozyme from plasma by glomerular filtration than it adds by a
hypothetical transtubular transport. Comparison of experiments
with binephrectomized donors and normal donors given a contin-
uous infusion to balance glomerular removal of lysozyme dem-
onstrates that no significant transtubular transport takes place.
The present study shows: (1) lysozyme is taken up in kidney tu-
bules by endocytosis and is catabolized in the lysosomes, (2)
transtubular transport of intact protein, if it exists at all, is less
than 9% of the lysozyme present in the tubules during the present
experimental conditions.
Comportement renal de Ia lysozyme chez le rat. Le but de cette
étude est d'analyser Ic comportement renal de la lysozyme et
plus particuliCrement de savoie s'il existe ou non on transport
tubulaire de lysozyme intacte. Trente minutes après l'injection
de 1251-lysozome, 41,3 (5EM) 1,7% de Ia dose injectée est accu-
mulée dans les reins oU elle est primitivement localisée dans les
lysosomes ainsi que Ic montrent les centrifugations dif-
férentielles et l'autoradiographie en microscopie electronique.
Trente minutes aprés l'injection de °51-lysozyme a on animal
(donneur), Ic sang de cet animal a Cté utilisé pour une circulation
croisée avec un autre animal (accepteur) et la captation de 125J
lysozyme par les reins de l'accepteur a été déterminée. La cap-
tation de 1251-lysozyme par les reins de l'accepteur est one me-
thode sensible de detection des faibles modifications de la con-
centration de '251-lysozyme dans le sang do donneur au cours de
différentes situations expérimentales. La comparaison des cx-
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périences faites avec des donneurs normaux et des donneurs bi-
nephrectomises montre que le rein soustrait plus de 121-lyso-
zyme do plasma par filtration glomerulaire qu'il n'en ajoute par
on hypothétique transport transtubulaire. La comparaison des
experiences réalisées avec des donneurs binephrectomisés et
des donneurs normaux recevant one perfusion continue destinée
a pallier Ia soustraction glomérulaire de lysozyme ne montre au-
con transport transtubulaire detectable. Le travail montre: (I)
que Ia lysozyme est captée par les tubes rénaux par endocytose
et qu'elle est catabolisée par les lysosomes, (2) que le transport
transtubulaire de protéine intacte, s'il existe, est inférieur a 9%
de la lysozyme presente dans les tubes dans les conditions ex-
pCrimentales utilisées.
There is considerable evidence that the kidney
plays an important role in the catabolism of low-
molecular-weight proteins, including several hor-
mones, which are filtered in the glomeruli [1-41.
Proteins in the tubule lumen are readily taken up by
the proximal tubular cells by endocytosis and are
transported to the lysosomes [5-7]. Recent studies
have demonstrated that the absorbed protein can be
digested in the lysosomes [8-10]. Although endo-
cytic uptake and lysosomal catabolism of protein in
the proximal tubule is widely accepted [4, 11-141,
the existence of an additional transtubular transport
of intact protein from the tubular lumen into the
peritubular capillaries is more controversial. Exper-
imental data in favor of transtubular transport of
lysozyme, in addition to lysosomal catabolism, has
been reported [13, 15, 161, but other lines of evi-
dence contradict transtubular transport of protein
9, 17].
The present study was addressed to the question
whether or not a transtubular transport of intact
protein takes place. We have analyzed the renal
handling of lysozyme, a protein of low molecular
weight, which is readily filtered in the renal glomer-
uli and extensively reabsorbed from the ultrafiltrate
[9, 18]. The principle of the experiments was to in-
ject i.v. a single dose of labeled lysozyme into rats
and to follow the blood concentration of the protein
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during experimental conditions simulating an in-
creased or decreased transtubular transport of pro-
tein. To obtain a sensitive determination of small
lysozyme concentrations in the blood, we used a
modification of the cross-circulation method of Just
et al [19].
The results of the present study provide further
evidence that the kidney plays a major role in the
catabolism of low-molecular-weight protein, but
they provide no evidence that filtered protein is
transported intact through the tubule wall.
Methods
Animals. Male, Wistar rats (each weighing 270 to
320 g) were used in all experiments. Preparation of
vascular shunts and nephrectomy were carried out
under short ether anaesthesia, and the animals were
heparinized with 150 IU of heparin. During cross
circulation, the rats were unanaesthetized and im-
mobilized in restriction cages.
'2I-Ivsozyme. Egg-white lysozyme (Sigma, grade
I) was labeled with carrier-free 125J (Amersham) us-
ing iodine monochloride [20]. The molar ratio of io-
dine monochloride to lysozyme was 1 : 1, and the
iodinated protein was separated from the iodination
reagents immediately after iodination on a G-25
Sephadex column and subsequently dialyzed against
0.85% sodium chloride at a pH of 3.0. The iodin-
ation efficiency was about 55%, and the specific ac-
tivity was 200 CiIrng of protein with less than 2%
free 1125.
The enzyme activity of 19-lysozyme [21] per mu-
ligram of protein was not less than 85% of that in
unlabeled lysozyme, and polyacrylamide gel elec-
trophoresis showed no difference in mobility be-
tween unlabeled and '251-labeled lysozyme (Otto-
sen, in preparation).
Before administration to the experimental ani-
mals, the '251-lysozyme was diluted with unlabeled
lysozyme from the same batch to give a final specif-
ic activity of 2 Ci/mg. This dilution was used in all
experiments, except for autoradiography where the
specific activity of the injected lysozyme was 200
Ci/mg.
Determination of GFR. The GFR was determined
in an initial series of 17 rats of the same weights as
the rats used in the cross-circulation experiments.
The animals were operated exactly like the donor
animals in the final experiments, but instead of
being cross-circulated with another animal, the
blood was pumped from the caval to the jugular
vein of the same animal (compare below under
"Cross circulation").
A solution of inulin (2.5 g/100 ml; Merck, Darm-
stadt) was given through the jugular vein (0.5 ml as
a primary injection followed by a continuous in-
fusion of 0.8 ml/hr), and the urine was collected
through a suprapubic bladder catheter. The inulin
concentration in blood and urine was determined
according to Zwiebel et al [221. The GFR in each
animal was determined as the average of two to six
clearance periods. The GFR in the whole series of
rats was 2.03 (sErf) 0.12 mllmin (N = 17).
Distribution of 1251-lysozyme. The concentration
of lysozyme in the blood at different time intervals
after i.v. injection of 1 mg of '2Thlysozyme (2 /LCiJ
mg) was determined in animals operated exactly as
described below for donor animals, and after 30 mm
some of these donor animals were connected to ac-
ceptor animals. Venous blood samples were collect-
ed through the venous-venous shunt. The total
amount of 1251-lysozyme in the blood, expressed as
percent of injected dose, was calculated with the as-
sumption that the total blood volume was 64 mL'kg
of body weight [231. The kidney content of lyso-
zyme was determined in animals from the same
group at different times after i.v. injection of the
protein. Lysozyme contents in liver, spleen, in-
testine, lungs, and thyroid were also determined by
counting whole organs.
In a separate series of experiments, the concen-
tration of lysozyme in the blood was determined in
binephrectomized animals injected with '251-lyso-
zyme.
Radioactivity measurements. Radioactivity was
determined with a gamma spectrometer (Selektro-
nik, Denmark). The whole kidneys were counted af-
ter decapsulation. Blood samples and kidney ho-
mogenates were precipitated with 10% TCA, and
TCA-soluble and TCA-precipitable radioactivity
were determined. Kidneys, other organs, and blood
samples were kept on ice until the radioactivity was
determined.
Cross circulation. A modification of the cross-cir-
culation method of Just et al [19] was used to follow
minor changes in the blood level of '251-lysozyme
injected into the experimental animal (donor ani-
mal).
A venous-venous (v-v) shunt was prepared in the
donor animal (Fig. 1). Thin polyvinylethylene cath-
eters (O.D., 1 mm) were used, and one catheter was
passed through the left femoral vein into the inferior
vena cava until its tip was located at the level of the
renal veins. Another catheter was placed in the left
jugular vein, and the blood was circulated through
this extracorporal v-v shunt with an adjustable
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Peristaltic pump
Jugular vein
Inferior vena cava —
— Femoral artery
DONOR ACCEPTOR
Fig. 1. Schematic drawing showing c'ross circulation between donor and acceptor. Venous blood from the donor's inferior vena cava was
pumped into the acceptor's femoral vein. The catheter was placed with its tip at the level of the renal veins. Arterial blood from the
acceptor's femoral artery was pumped into the donor's jugular vein. The same peristaltic pump was used to circulate blood from donor to
acceptor and Irom acceptor to donor, Arrows show direction of blood flow.
small peristaltic pump. In another animal (acceptor
animal), an arteriovenous (a-v) shunt was prepared
by connecting the left femoral artery to the left fern-
oral vein. A solution containing 1 mg of 1251-lyso-
zyme (specific activity, 2 .tCiImg) in 0.1 ml of Ring-
er solution was given i.v. to the donor animal.
Venous blood samples (0.1 ml) were collected in
heparinized plastic tubes at different time intervals
from the caval catheter in the donor.
Cross circulation of blood between donor and ac-
ceptor animals was started 30 mm after i.v. adminis-
tration of 1251-lysozyme to donor animals in all ex-
periments. The same peristaltic pump was used to
pump blood from donor to acceptor and from ac-
ceptor to donor. Cross circulation from donor to ac-
ceptor was done by pumping blood from the do-
nor's caval catheter into the acceptor's venous
catheter (Fig. 1). The blood coming from the do-
nor's inferior vena cava originated from a low-pres-
sure vessel, and thus the pump sucked blood from
this vein. Cross circulation from acceptor to donor
was done by pumping blood from the acceptor's ar-
terial catheter into the donor's jugular vein (Fig. 1).
The acceptor animal's body weight was constantly
followed and not allowed to fluctuate beyond 0.50
g during the cross-circulation period. The blood
coming from the acceptor was arterial blood under
high pressure, and the function of the pump here
was to restrict the blood flow from acceptor to do-
nor. Since the arterial flow from acceptor to donor
was constant, a constant body weight of the accep-
tor indicated a constant blood flow during the cross-
circulation period. Only experiments with a con-
stant blood flow above 0.5 mI/mm were included in
the results. The cross circulation lasted for 30 mm,
and at the end of the experiment, the blood flow
from donor to acceptor was measured by determin-
ing the volume of blood pumped out of the donor's
caval catheter for 1 mm. The uptake of 1251-lyso-
zyme in the acceptor kidneys was determined and
expressed as microgram of '251-lysozyme per millili-
ter of blood pumped from donor to acceptor per
minute (pjg . m1' . min).
Cross circulation was carried out in the following
four experimental groups (Fig. 2):
Group N. Normal donors comprised this group.
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Group N + infusion. Normal donors were given a
continuous infusion of '251-lysozyme through a cath-
eter in the right jugular vein. This infusion was giv-
en to balance the removal of 1251-lysozyme from the
blood by glomerular filtration, and the infusion rate
corresponded to the rate at which lysozyme was fil-
tered in the kidney. The amount of filtered lyso-
zyme was calculated as inulin clearance x plasma
level of lysozyme (gIml) x sieving coefficient for
lysozyme. The plasma level of lysozyme in donors
45 mm after injection of lysozyme was taken as the
average plasma level in donors during cross circula-
tion. Inserting the appropriate values for GFR (see
above), plasma level (see "Results"), and sieving
coefficient [18], the amount of filtered lysozyme is
2.03 x 2.99 x 0.7 = 4.25 gImin. Thus, 128 .tg of
lysozyme was infused in 30 mm.
Group B: Binephrectoinized donors. Both kid-
neys were removed from the donor animals 30 mm
after injection of '251-lysozyme immediately before
start of cross circulation.
Group B + infusion. Binephrectomized donors
were given a continuous infusion of '251-lysozyme
through the right femoral vein to test the sensitivity
of the cross-circulation method. The infused
amount of 1251-lysozyrne was adjusted to corre-
spond to 11.0% of the donor kidney content of 12J
lysozyme.
Isolation of Ivsosomes. The subcellular local-
ization of '2I-lysozyme was studied in five experi-
ments in which the animals were prepared as de-
scribed for donor animals and injected i.v. with 1
mg of 1251-lysozyme (specific activity, 2 1sCilmg).
The kidneys were removed 30 mm after injection of
1251-lysozyme, and the kidney cortex was homoge-
nized in a 0.3-M sucrose solution. Subcellular frac-
tions were isolated by differential centrifugation
124]. The fractions were assayed for radioactivity,
acid phosphatase activity, and protein concentra-
tion [25J. Acid phosphatase was assayed at a pH of
5.0 with /3-glycerophosphate as a substrate. Liber-
ated phosphate was determined by a modification of
the method of Fiske and Subbarow [26] with amidol
as a reducing agent. In two control experiments,
kidney cortex from noninjected animals was ho-
mogenized in 0.3 M sucrose as above except that the
sucrose solution contained 0.2 mg of '2Thlysozyme/
kidney cortex. Isolation of subcellular fractions was
then carried out as described above to determine a
possible nonspecific binding of 1251-lysozyme to the
lysosomal fraction.
Electron microscope autoradiographv. The kid-
ney was fixed 30 mm after i.v. injection of 1 mg of
25I-lysozyme (specific activity, 200 Ci/mg) by in-
travascular perfusion with 1% glutaraldehyde in a
modified Tyrodes solution. The tissue was post-
fixed in osmium and prepared for electron micro-
scope autoradiography [6]. Electron microscopy
was carried out with a JEM-l00-B or JEM-lOO-C
microscope. Electron micrographs from proximal
tubules were analyzed at a final magnification of ><
15,000, and grains were counted over lysosomes
and L-cytoplasm (cytoplasm within 0.5 p from the
lysosomes) and endocytic vacuoles, EV-cytoplasm
(cytoplasm within 0.5 t from the endocytic vacu-
oles), cytoplasm (cytoplasm exclusive of L- and
EV-cytoplasm), nuclei, and brush border. Areas of
the cytoplasmic regions were determined with point
Group N Group B
PL
GF=0
TT=0
Group N + nf. Group B + nf.
4
GFO
PL K
TT=0
Fig. 2. Schematic drawing showing the four experimental groups
of donors used for cross circulation. Group N: Normal donor.
Group B: Binephrectomized donor. In these donors both kidneys
were removed 30 minutes after injection of 251-lysozyme im-
mediately before start of cross circulation. Group N + inf Nor-
mal donor into which a continuous infusion of '251-Iysozyme was
given through the jugular vein to balance the glomerular filtration
of '251-lysozyme. Group B + inf Binephrectomized donor into
which a continuous infusion of '251-lysozyme was given through
the femoral vein to test the sensitivity of the system. Such an
infusion mimics a possible transtubular transport. The infused
'251-lysozyme passes directly from the femoral vein into the infe-
rior vena cava at the site where a possible transtubular transport
would release lysozyme into the blood. PL is plasma level of
lysozyme, GF is glomerular filtration of lysozyme, TT is trans-
tubular transport of lysozyme, K is kidney, and I is continuous
infusion of lysozyme.
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counting. Grain density was expressed as grains!
l00!2.
Statistical methods. Experimental values were
compared using Student's t test. Significance was
accepted at the 5% level (2 P < 0.05).
Results
Distribution of '2I-lysozyme afer i.v. injection.
The blood level of 25I-Iysozyme in donor animals
decreased rapidly after i.v. administration (Fig. 3).
During the period of cross circulation, from 30 to 60
mm after injection of labeled protein, the total
amount of lysozyme in the blood decreased from
5.65 0.33 to 3.89 (sEM) 0.25% of the injected
dose. The plasma concentration of lysozyme 45 mm
after injection was 2.99 (sEM) 0.14 g!m1 (N =
12).
In animals binephrectomized before injection,
there was a slower decrease in the blood level of
251-lysozyme. After 30 mm, 18.7 0.23% (N = 3)
of the injected dose remained in the blood, an
amount which is significantly higher than that in
normal animals (2 P < 0.001).
The TCA-soluble radioactivity in blood was 3.5%
15 mm after injection and increased gradually to
16.6% after 60 mm. The TCA-soluble radioactivity
in blood from binephrectomized animals 60 mm af-
ter injection of '251-lysozyme was lower (6.2%) than
it was in normal animals.
The maximum accumulation of 1251-lysozyme in
the kidneys, 41.3 (sEM) 1.7% of the injected
amount, was observed 30 mm after injection, and
during the following hours there was a gradual de-
crease in kidney content of radioactivity (Fig. 4).
The TCA-soluble radioactivity in kidney homoge-
nates was less than 6% of the total radioactivity in
both donor and acceptor kidneys.
Compared to the kidneys, other organs contained
only small amounts of radioactivity 1 hour after in-
jection of '251-lysozyme (liver, 5%; intestine, 1.9%;
lung, 0.7%; spleen, 0.3%). The thyroid gland of nor-
mal donors contained 0.4% of the injected radio-
activity after 1 hour and 4.0% after 5 hours.
Subcellular localization of 251—lvsozynze in the
kidney: (A) Differential centrfugation. Determina-
tion of radioactivity in subcellular fractions isolated
from the kidney cortex by differential centrifugation
30 mm after i.v. injection of '251-lysozyme revealed
50
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Fig. 4. Lysozyrne accumulation in the kidney.' at various inter
va/s after i.e. injection. Theamount of lysozyme in the kidneys is
expressed as percent of injected dose (mean SD).
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Fig. 3. Lysozyme level in blood after iv. injection. The ordinate
shows the total amount of lysozyme remaining in the blood as
percent of injected dose (mean so).
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an accumulation of '251-lysozyme in the lysosomal
fraction (Fig. 5). Labeled lysozyme was enriched
4.1 times and acid phosphatase 3.3 times in the lyso-
somal fraction as compared to the homogenate. In
the control experiments where 1251-lysozyme was
added to kidney cortical homogenates from non-
injected animals, there was no enrichment of 125J..
lysozyme in the lysosomal fraction, the relative spe-
cific activity being 0.17.
(B) Autoradiography. Electron microscope auto-
radiography of proximal tubules revealed that most
grains were located over lysosomes or endocytic
vacuoles (Fig. 6). Out ofa total of 911 grains, 80.1%
were located over the lysosomes and L-cytoplasm,
and 14.9% were located over endocytic vacuoles
and EV-cytoplasm. The concentration of grains
over the lysosomes was 151 grains/l00 x2, and it
was 29.8 grains/100 jx over the endocytic vacuoles.
The concentration of grains over cytoplasm exclu-
sive of L-cytoplasm and EV-cytoplasm (cytoplasm
within 0.5 i from lysosomes or endocytic vacuoles)
was 0.5 grains/100 x2, which was very close to the
background (0.4 grains/100 x2). The grain density
over the brush border and nuclei was 0.8 and 0.5,
respectively.
Cross circulation. The amount of lysozyme in the
acceptor kidneys after cross circulation with normal
donors was 14.5 (8EM) 1.2 j.tg ml1 . min'
(group N, Table 1).
In experiments in which a continuous infusion of
12I-lysozyme was given to normal donors through
the jugular vein to balance the calculated removal of
lysozyme from the blood by glomerular filtration
(group N + infusion, Table 1), the uptake in the ac-
100% ceptor kidneys was not significantly different from
experiments with binephrectomized donors (group
B, Table 1). Thus, when the removal of lysozyme
by glomerular filtration is balanced by a continuous
infusion of the same amount of '251-lysozyme, no
net addition or release of lysozyme from the kidney
can be detected.
To evaluate the sensitivity of the method, we
100% gave a continuous infusion of '251-lysozyme to bi-
nephrectomized donors through a catheter in the
right femoral vein to mimic a net release of '251-lyso-
zyme from the kidney when no filtration of lyso-
zyme takes place. An infusion corresponding to
11.0% of donor kidney content caused a significant
increase (P < 0.02) in the content of radioactive
lysozyme (group B + infusion, Table 1) of acceptor
kidneys.
An infusion corresponding to 6% of donor kidney
content also gave an increase in acceptor kidney
content, but this increase was not statistically sig-
nificant in five experiments.
Discussion
The findings in the present study suggest that
there is no significant transtubular transport of in-
tact protein in the kidney and that the reabsorbed
lysozyme is catabolized in the lysosomes of the
proximal tubule.
The present study confirms previous findings 127]
that a considerable portion of i.v. injected lysozyme
lz5Ilysozymee
Groupb p.g/ml blood/mm
Group N 14.5 1.2(N = 5)
Group N
GroupB
Group B
+ infusion
+ infusion
19.5
20.9±
29.8
1.1(N = 6) 1 NS1.l(N=5)
2.5 (N = 5)
L
N
Acid phosphatase
4
3
2
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1251-Iysozyme
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Percent of total protein
Fig. 5. Distribution of acid phosphatase and 1251-lysozyme in sub-
cellularfractionsfro,n kidney cortex. The ordinate gives the rela-
tive specific activity (activity in fraction in percent of total activi-
ty in homogenate/protein in fraction in percent of total protein in
homogenate) and the abscissa the percent of total protein in the
different fractions. N is nuclear fraction, L is lysosomal fraction,
M is mitochondrial fraction, B is brush border fraction, and S is
supernatant.
Table 1. 12%-lysozyme in acceptor kidneys after cross
circulationa
a Values are means SEM.
hGroup N is comprised of normal donors; group N + infusion,
normal donors infused to balance glomerular filtration of lyso-
zyme; group B, binephrectomized donors; group B + infusion,
binephrectomized donors infused to test the sensitivity of the
system.
Asterisks denote 2 P < 0.02.
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Fig. 6. Electron microscope autoradiograph ofproximal tubule 30 mm after injection (t 12°J-lysozyme. Autoradioagraphic grains are seen
located almost exclusively over lysosomes (arrows) and endocytic vacuoles (arrowheads). 1. is lysosome, EV is endocytic vacuole, BB is
brush border, N is nucleus, and BM is basement membrane (magnification x9,500).
is taken up in the kidney and in particular in the
cortex [28]. Previous studies with light microscope
autoradiography have demonstrated that 1251-lyso-
zyme was primarily located in the proximal tubule
cells, where it was preferentially associated with
lysosomes [161. In addition, a finite number of
grains were observed in the basal part of the cells,
but the resolution of the light microscope was not
sufficient to distinguish whether these grains were
located free in the cytoplasm or whether they were
associated with small cell organelles. In the present
study, the electron microscope autoradiography
showed that 1251-lysozyme was present either in
lysosomes or in endocytic vacuoles and that the
grain density over the cytoplasm was very close to
background. These observations are in agreement
with previous findings on lysozyme [91 and other
proteins [6].
The preferential accumulation of 1251-lysozyme in
the lysosomes was further supported by the dif-
ferential centrifugation data which demonstrated an
enrichment of lysozyme in the lysosomal fraction.
The localization of a fraction of acid phosphatase
and lysozyme in the supernatant is due to the inevi-
table damage to lysosomes during homogenization
[17].
That '251-lysozyme is catabolized in kidney slices
incubated in vitro [91 and in the isolated perfused rat
kidney [13, 181 has been demonstrated previously.
The present in vivo observations also suggest a ren-
al digestion of '251-lysozyme. The maximal accumu-
lation of '251-lysozyme in the kidney, 41.3% of the
injected dose, was observed after 30 mm when the
major part of '251-lysozyme was located in the lyso-
somes, as demonstrated by autoradiography. Dur-
ing the following hours, there was a fall in the
amount of '251-lysozyme in the kidney. Since there
was a significant increase in TCA-soluble radio-
activity in the blood from 15 to 60 mm in normal
animals, and a significantly smaller amount of TCA-
soluble radioactivity in binephrectomized animals,
the fall in 251-lysozyme content in the kidney is con-
sistent with a digestion of 251-lysozyme in kidney
lysosomes. The catabolic products of 251-lysozyme
'S
/
'-a-s
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which contain 125J, including monoiodotyrosine, are
deiodinated in renal tissue [9, 131. The observed up-
take of radioactivity in the thyroid gland presum-
ably represents to a large extent radioactive iodine
released from the kidney. These observations con-
firm and extend the view that lysozyme filtered in
the glomeruli is reabsorbed in the proximal tubule
by endocytosis and is transferred to the lysosomes
where it can be catabolized.
A hypothetical transtubular transport of protein
would, in addition to endocytic uptake and iyso-
somal digestion, constitute a third mechanism in-
fluencing the kidney content of lysozyme. Such a
transtubular transport of protein, however, would
be difficult to measure directly, but if it exists it can
be expected to influence the lysozyme content of
the blood. Thus, by determining the blood level of
9lysozyme during different experimental condi-
tions, information on a possible transtubular trans-
port may be obtained. The cross-circulation proce-
dure provides a sensitive method for determinations
of differences between low blood levels of lyso-
zyme.
The amount of lysozyme in the acceptor's kid-
neys is proportional to the blood level of lysozyme
in the donor animal during cross circulation, since
the kidneys in the acceptor continuously accumu-
late a fraction of the radioactive lysozyme trans-
ferred from donor to acceptor. Small increases or
decreases in the level of lysozyme in the donor's
blood, therefore, will be detectable as changes in
the radioactivity of the acceptor kidneys, and since
a possible transtubular transport of lysozyme would
increase the level of lysozyme in the donor's renal
venous blood, the catheter transferring blood from
donor to acceptor was placed in the vena cava at the
level of the renal veins.
In experiments with normal donors, both gb-
merular filtration and a hypothetical transtubular
transport of 2I-lysozyme will influence the plasma
level simultaneously (group N, Fig. 2). The demon-
stration of a significantly higher uptake of 1251-lyso-
zyme in acceptor kidneys in experiments with bi-
nephrectomized donors as compared to normal do-
nors shows that the kidney removes more 12J
lysozyme from the blood by gbomerular filtration
than it adds by a hypothetical transtubular trans-
port.
The magnitude of a possible transtubular trans-
port was estimated in experiments in which the re-
moval of '9-lysozyme from plasma in normal do-
nors was balanced by an i.v. infusion of 1251-lyso-
zyme (group N + infusion, Fig. 2) corresponding to
the glomerular filtration of '251-lysozyme, which
was calculated as described in Methods." In this
case, a transtubular transport of intact protein
would result in a net addition of lysozyrne to the
blood. Thus, the plasma level of 19-lysozyme in
these normal donor animals would be higher than
the plasma level in binephrectomized donors if a
transtubular transport of intact lysozyme takes
place. Since there was no difference in the amount
of 1251-lysozyme in acceptor kidneys after cross cir-
culation with binephrectomized donors and with
normal donors infused with lysozyme to balance the
gbomerular filtration, these results contradict the ex-
istence of a significant transtubular transport of
lysozyme. Our conclusion regarding transtubular
transport of lysozyme should be related also to the
ability of the cross-circulation method to detect a
net addition of '251-lysozyme from the kidney to the
blood. To test the sensitivity of the method, we in-
duced a mimic of transtubular transport by a contin-
uous infusion of '2I-lysozyme into the femoral vein
of binephrectomized donor animals. Lysozyme in-
fused in this manner passes directly into the inferior
vena cava and corresponds to a continuous release
of 1251-lysozyme from the renal veins due to a hypo-
thetical transtubular transport. Since an infusion
corresponding to 11% of the donor kidney content
of '2I-lysozyme gave a significant increase in ac-
ceptor kidney content of '2I-lysozyme, trans-
tubular transport of lysozyme, if it exists at all,
must be less than 11% of the amount of lysozyme
accumulated in the kidney. The total amount of
lysozyme that is potentially available for trans-
tubular transport in the kidney during the cross-cir-
culation period, however, can be calculated to be
541 tg and includes the lysozyme present at the be-
ginning of cross circulation (41.3% of injected dose,
corresponding to 413 g) plus the lysozyme which
is filtered during cross circulation (128 g, see
"Methods") and which is almost quantitatively
reabsorbed. Thus, the amount of 1251-lysozyme that
is possible to be detected as a net addition to the
blood during cross circulation (11% of 413 g) rep-
resents only 8.4% of the lysozyme available for
transtubular transport. It is concluded, therefore,
that under the present experimental conditions
transtubular transport of lysozyme, if it exists at all,
is less than about 9% of the protein potentially
available for transport.
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